Worth Asset Management’s Novartis NVS Stock Holding History

Worth Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-672	Closed	-$67.8K	–	301
2023 Q2	$67.8K	Buy	672 +170	+34%	+$17K	0.05%	165
2023 Q1	$46.2K	Buy	502 +402	+402%	+$35.1K	0.04%	186
2022 Q4	$9.07K	Hold	100	–	–	0.01%	315
2022 Q3	$8K	Hold	100	–	–	0.01%	302
2022 Q2	$8K	Hold	100	–	–	0.01%	371
2022 Q1	$9K	Buy	+100	New	+$8.66K	0.01%	357

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Worth Asset Management's NVS Position: Q3 2023 in Review

Worth Asset Management sold out of Novartis (NVS) in Q3 2023, closing a stake of 672 shares — an estimated $67.8K sold.

Worth Asset Management first reported a position in NVS in Q1 2022 and held it in 6 quarters. The position peaked at $67.8K in Q2 2023. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Worth Asset Management reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 672 Novartis shares in Q3 2023, an estimated $67.8K.
Worth Asset Management first reported a position in Novartis in Q1 2022 and held it in 6 quarters.
Worth Asset Management's Novartis position peaked at $67.8K in Q2 2023.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.